Order 7849681

docx

School

University of Nairobi *

*We aren’t endorsed by this school

Course

1

Subject

Nursing

Date

Nov 24, 2024

Type

docx

Pages

5

Uploaded by petertoshtutor

Report
1 The Adverse Effects of Gadolinium Agents and Their Management Student’s Name Institutional Affiliation Course Name and Number Instructor’s Name Assignment Due Date
2 The Adverse Effects of Gadolinium Agents and Their Management Gadolinium contrast agents, or GBCAs, are commonly used in MRI scans to enhance the visibility of blood vessels and organs. However, in some instances, the effects of Gadolinium can be adverse. A patient may experience complications during or after the scan due to an allergic reaction, or they may experience a more severe condition, such as Nephrogenic Systemic Fibrosis (Isaka et al., 2020). This paper will explore gadolinium-based contrast agents' adverse effects and how they can be managed. Topics such as their action mechanism, purpose, and available treatments will be discussed. It will also address the importance of informed consent in administering gadolinium-based contrast agents. Purpose of Using Iodinated Contrast Agents Iodinated contrast agents (ICA) are chemical compounds that enhance the visibility of internal organs and tissues during specific medical imaging procedures. These agents fill a cavity or blood vessel, making it easier for imaging equipment to produce an image ( Pasternak & Williamson, 2012). ICA can be administered intravenously, orally, or through percutaneous techniques such as catheters or endoscopes. They allow radiologists to identify diseases and evaluate the body internally ( Pasternak & Williamson, 2012). The primary purpose of using ICA is to produce a clear image of internal organs and structures when conventional imaging techniques do not provide an acceptable level of contrast or clarity. ICA differentiates between healthy and abnormal tissues in X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) procedures. For instance, when used to evaluate a particular organ, the contrast agent allows abnormalities such as tumors and blockages to be detected (Isaka et al., 2020). ICA also contrasts specific organs' functional activities to detect medical conditions. For example, nuclear medicine procedures require using ICA to help diagnose conditions such as cardiovascular disease, cancer, and liver and kidney disease. ICA improves the accuracy of diagnoses and enhances the radiologist’s ability to image and interpret. Administration of Gadolinium Agents Iodinated contrast agents are administered intravenously via injections or by intravenous drip. There are two types of agents, ionic and non-ionic agents, which are taken up by organs and tissues differently. Generally, iodinated contrast agents are available as aqueous solutions in a concentration range of 0.5 to 2 mL containing 150 or 300 mg of iodine (more concentrated solutions are available for direct administration without dilution) ( Pasternak & Williamson,
3 2012). The most common doses range from 50-150 mg of iodine per kilogram of the patient’s body weight, with variations depending on the condition for which the agent is being used. Gadolinium-based contrast agents (GBCA) enhance excellent contrast in magnetic resonance imaging (MRI). They are usually available as aqueous solutions with concentrations ranging from 0.1 to 0.5 mL containing gadobenate dimeglumine, gadopentetate dimeglumine, or gadoteridol (Isaka et al., 2020). The dose depends on the patient’s body weight and the type and concentration of GBCA used. Generally, a dose of 0.1 to 0.2 mmol/kg is recommended for all approved GBCA. Due to potential safety issues, gadolinium-based contrast agents should only be administered under medical supervision ( Pasternak & Williamson, 2012). Before administering any production of GBCA, the administering physician should review the product’s labeling and ensure that any safety issues are addressed during the injection process. Side Effects of Gadolinium Agents Iodinated contrast agents can cause side effects, including mild allergic reactions, nausea, vomiting, headaches, and tingling or burning sensations. Though rare, more severe reactions can include renal dysfunction, which could lead to kidney failure, anaphylactic shock, or anaphylactoid reactions that can cause throat tightness, difficulty breathing, and shock ( Cha et al., 2019). Some people will not experience any of these side effects, but those with preexisting kidney problems, diabetes, allergies, or inflammatory bowel syndrome have a greater risk (Cha et al., 2019). Discussing all existing medical conditions with the healthcare team before having an imaging procedure with Gadolinium is essential. Patients are also warned to stay well hydrated before and for 48 hours after an imaging procedure to flush out any remaining contrast material in the body ( Morcos, 2008). Those with kidney problems need to stay well hydrated as their kidneys may have difficulty eliminating the material from the body. In addition, Gadolinium has been associated with a rare condition called nephrogenic systemic fibrosis (NSF). This condition is characterized by thickened, hardened, and discolored skin and can occur in individuals with kidney problems who are exposed to gadolinium- containing contrast medium ( Morcos, 2008). It is recommended only to use contrast agents containing Gadolinium in patients with moderate to severe kidney problems if necessary, and the benefits outweigh the risks. Overall, iodinated contrast agents such as Gadolinium are generally considered safe and are well tolerated by healthy individuals ( Morcos, 2008). However, it is essential to discuss existing medical conditions with the healthcare team before having an
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
4 imaging procedure and to stay well hydrated to reduce the risk of side effects and potentially more severe reactions. Effective Management of Side Effects Some common side effects of Iodinated contrast agents, such as Gadolinium, include nausea, vomiting, shivering, kidney problems, and skin rash. To manage these side effects effectively, keeping the patient adequately hydrated before and after the procedure is essential to minimize potential side effects ( Morcos, 2008). In addition, medications such as antihistamines, analgesics, and sedatives may be prescribed to reduce any discomfort associated with the contrast agent. It is also essential to monitor the patient closely during the procedure for any signs of an adverse reaction and alert the healthcare team if there is any change ( Morcos, 2008). Ultimately, ensuring the patient is well-informed and educated is essential to ensure an effective procedure and the best possible outcome.
5 References Cha, M. J., Kang, D. Y., Lee, W., Yoon, S. H., Choi, Y. H., Byun, J. S., & Kang, H. R. (2019). Hypersensitivity reactions to iodinated contrast media: A multicenter study of 196 081 patients. Radiology , 293 (1), 117-124. https://doi.org/10.1148/radiol.2019190485 Isaka, Y., Hayashi, H., Aonuma, K., Horio, M., Terada, Y., Doi, K., & Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group. (2020). Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Japanese Journal of Radiology, 38 , 3-46. https://doi.org/10.1007/s11604- 019-00850-2 Morcos, S. K. (2008). Adverse reactions to iodinated contrast media. Cancer Imaging , 97-106. https://doi.org/10.1016/B978-012374212-4.50080-8 Pasternak, J. J., & Williamson, E. E. (2012, April). Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: A primer for the non-radiologist. In Mayo Clinic Proceedings (Vol. 87, No. 4, pp. 390-402). Elsevier. https://doi.org/10.1016/j.mayocp.2012.01.012